Why Pfizer Just Hiked Its Guidance By $500 Million - Investor's Business Daily
Source:Investor's Business Daily
Pfizer beat second-quarter expectations Tuesday, offsetting a continued steep decline for its Covid products.
Related Articles
Prediction: This Artificial Intelligence (AI) Chip Stock Will Become the Next Nvidia by 2030 - The Motley Fool
Broadcom’s revenue from artificial intelligence chips is poised to take off remarkably in the …
What are peptides, and are they safe? Here's what to know - PBS
Lots of people are talking about peptides. But what are they? Here’s a quick primer on the health …
GLP-1 drugs are changing how Americans eat. Food companies are racing to catch up - CNBC
For restaurants and food companies, the increasing adoption of GLP-1 drugs present both an …
Nvidia suppliers halt H200 output after China blocks chip shipments - Financial Times
Parts makers concerned about whether Beijing will allow imports of AI processors